Evaluation and management of hepatitis B in pregnancy: A survey of current practices

Gastroenterology and Hepatology

Volumn 6, Issue 9, 2010, Pages 570-578

  Ahn, Joseph ^a,b   Salem, Suhail B ^c   Cohen, Stanley Martin ^b  

^a Department of Medicine ^*  (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiviral therapy; Hepatitis B; Hepatitis B immunoglobulin; Practice patterns; Pregnancy

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; INTERFERON; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR;

ANTIVIRAL THERAPY; BREAST FEEDING; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PATIENT SATISFACTION; PREGNANCY; PUERPERIUM; REVIEW; TREATMENT RESPONSE; VERTICAL TRANSMISSION;

EID: 77958546914     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11: 97-107.
2. McQuillan GM, Coleman PJ, Kruszon-Moran D, Mover LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14-18.
3. National Center for Health Statistics. Table 51. Selected notifiable disease rates and number of cases: United States, selected years 1950-2005. Available at: http://www.cdc.gov/nchs/data/hus/hus07.pdf#051. Accessed February 9, 2009.
4. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191-211.
5. Chen CJ, Wang LY, Yu MW. Towards control of hepatitis B in the Asia-Pacific region. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15(S2):E3-E6.
6. Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346:1682-1683.
7. Yao JL. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut. 1996;38(S2):S37-S38.
8. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis. 1998;27:100-106.
9. del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15:1624-1630.
10. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004;10:910-912.
11. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294-297.
12. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Vital Hepat. 2009;16:94-103.
13. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002;359: 1488-1489.
14. Centers for disease control and prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR Morb Mortal Wkly Rep. 2005;54:1-23.
15. Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology. 2009;50:1-36.
16. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936-962.
17. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315-1341.
18. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45:1056-1075.
19. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539.
20. Gartner LM, Morton J, Lawrence RA, et al; American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496-506.
21. Epivir [package insert]. Research Triangle Park (NC): GlaxoSmithKline; 2008.
22. Hepsera [package insert]. Foster City (CA): Gilead Sciences; 2008.
23. Baraclude [package insert]. Princeton (NJ): Bristol-Myers Squibb; 2008.
24. Tyzeka [package insert]. East Hanover (NJ): Novartis Pharmaceutical Corp; 2009.
25. Viread [package insert]. Foster City (CA): Gilead Sciences; 2008.
26. The Antiretroviral Pregnancy Registry. Available at: http://www. apregistry.com. Accessed February 9, 2009.
27. Sorrcll MF, Belongia EA, Costa J, et al. National Institutes of Health consensus development conference statement: management of hepatitis B. Ann Intern Med. 2009;150:104-110.